Applications of Myosin1b gene or protein

• Main Authors: ZHOU JUEYU, SHI RONG, ZHANG HANRONG, HUANG LIJUN, LIU JIE
• Format: Patent
• Language: Chinese; English
• Published: 26.01.2018
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention discloses applications of Myosin1b gene or protein, and belongs to the field of gene detection. it is found that Myosin1b gene expression is related to cervical cancer for the first time; and it is possible to determine whether a human subject is suffered from cervical cancer, or the cervical cancer risk of the human subject via detecting the expression situations of Myosin1b in cervical mucous membrane of the human subject, and help clinical doctors to provide the human subject with protection or therapeutic schedules. The molecular marker-Myosin1b gene which can be used for cervical cancer clinical diagnosis and targeted therapy is disclosed. Compared with traditional cervical cancer diagnosis and treatment methods, detection, diagnosis, and treatment of cervical cancer with the gene marker possess following advantages: timeliness, specificity, and sensitivity are excellent, it is beneficial for prediction of cancer risk, drawing of therapeutic schedule with pertinency,and accurate assessment